Exhibit 99.1

 

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION

 

Introduction

 

On September 25, 2022, Inpixon (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, KINS Technology Group Inc., a Delaware corporation (“KINS”), CXApp Holding Corp., a Delaware corporation and newly formed wholly-owned subsidiary of Inpixon (“CXApp” and, together with Inpixon, collectively, the “Companies”), and KINS Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of KINS (“Merger Sub”), pursuant to which KINS will acquire Inpixon’s enterprise apps business (including its workplace experience technologies, indoor mapping, events platform, augmented reality and related business solutions) (the “Enterprise Apps Business”) in exchange for the issuance of shares of KINS capital stock valued at $69 million (the “Business Combination”) to be issued to Inpixon stockholders.

 

The Merger Agreement, along with the Separation Agreement and the other transaction documents to be entered into in connection therewith, provides for, among other things, the consummation of the following transactions: (i) Inpixon will transfer the Enterprise Apps Business (the “Separation”) to its wholly-owned subsidiary, CXApp, and contribute $10 million in cash (the “Cash Contribution”), (ii) following the Separation, Inpixon will distribute 100% of the shares of CXApp Common Stock to Inpixon stockholders and other security holders by way of the Distribution and (iii) following the completion of the foregoing transactions and subject to the satisfaction or waiver of certain other conditions set forth in the Merger Agreement, the parties shall consummate the Merger. The Separation, Distribution and Merger are intended to qualify as “tax-free” transactions.

 

The following unaudited pro forma condensed consolidated financial information is presented in accordance with the rules specified by Article 11 of Regulation S-X promulgated by the U.S. Securities and Exchange Commission (the “SEC”) and has been prepared subject to the assumptions and adjustments as described in the notes thereto. Specifically, the unaudited pro forma condensed consolidated financial information set forth below reflects the effects of the Business Combination on (i) the Company’s condensed consolidated balance sheet as of June 30, 2022, as if the Business Combination had occurred on that date, and (ii) Company’s condensed consolidated statement of operations for the six months ended June 30, 2022, and the year ended December 31, 2021, as if the Business Combination had occurred on January 1, 2021. Management believes that the assumptions used, and adjustments made are reasonable under the circumstances and given the information available.

 

The following unaudited pro forma condensed consolidated financial statements have been derived from historical financial statements prepared in accordance with U.S. generally accepted accounting principles (“US GAAP”). The pro forma adjustments reflect the impacts of events directly attributable to the Business Combination, that are factually supportable, and for purposes of the unaudited pro forma condensed consolidated statements of operations, expected to have a continuing impact on the Company. The following unaudited proforma condensed consolidated financial information is for illustrative and informational purposes only and is not necessarily indicative of the financial condition or results of operations of the Company that would have occurred if the Business Combination had occurred on the dates indicated, nor is it indicative of the future financial condition or results of operations of the Company.

 

The unaudited pro forma condensed consolidated financial information should be read in conjunction with the following:

 

The accompanying notes to the unaudited pro forma condensed consolidated financial statements;
The Company’s unaudited condensed consolidated financial statements as of and for the six months ended June 30, 2022, included in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2022; and
The Company’s audited consolidated financial statements as of and for the year ended December 31, 2021, included in its Annual Report on Form 10-K for the year ended December 31, 2021.

 

The historical condensed consolidated statement of operations for the year ended December 31, 2021, has been adjusted by Company management to reflect certain reclassifications to conform with current financial statement presentation.

 

 

 

 

INPIXON AND SUBSIDIARIES

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET

As of June 30, 2022

(In thousands, except number of shares and par value data)

 

    Inpixion and
Subsidiaries
Historical
(a)
    Pro Forma
Adjustments
    Note   Inpixion and
Subsidiaries Pro
Forma
 
                       
Assets                            
                             
Current Assets                            
Cash and cash equivalents   $ 65,755     $ (10,000 )   (c), (d)   $ 55,755  
Accounts receivable, net of allowances     2,767       (1,231 )   (c)     1,536  
Other receivables     311       (36 )   (c)     275  
Inventory     1,581       (10 )   (c)     1,571  
Note receivable     5,967       -           5,967  
Prepaid expenses and other current assets     3,463       (1,503 )   (c)     1,960  
                             
Total Current Assets     79,844       (12,780 )         67,064  
                             
Property and equipment, net     1,348       (215 )   (c)     1,133  
Operating lease right-of-use asset, net     1,582       (847 )   (c)     735  
Software development costs, net     1,647       (562 )   (c)     1,085  
Investments in equity securities     582       6,090     (e)     6,672  
Long-term investments     2,500       (2,500 )   (e)     -  
Intangible assets, net     30,126       (21,450 )   (c)     8,676  
Other assets     217       (53 )   (c)     164  
                             
Total Assets   $ 117,846     $ (32,317 )       $ 85,529  
                             
Liabilities and Stockholders’ Equity                            
                             
Current Liabilities                            
Accounts payable   $ 900     $ (327 )   (c)     573  
Accrued liabilities     4,116       (2,087 )   (c)     2,029  
Operating lease obligation, current     600       (266 )   (c)     334  
Deferred revenue     3,638       (2,452 )   (c)     1,186  
Short-term debt     1,911       -           1,911  
Acquisition liability     3,486       -           3,486  
                             
Total Current Liabilities     14,651       (5,132 )         9,519  
                             
Long Term Liabilities                            
Operating lease obligation, noncurrent     1,022       (602 )   (c)     420  
Other liabilities, noncurrent     28       (30 )   (c)     (2 )
                             
Total Liabilities     15,701       (5,764 )         9,937  
                             
Commitments and Contingencies                            
                             
Mezzanine Equity                            
Series 8 Convertible Preferred Stock- 53,197.7234 shares authorized; 53,197.7234 issued and outstanding as of June 30, 2022, respectively. (Liquidation preference of $53,197,723)     48,158       -           48,158  
                             
Stockholders’ Equity                            
Common Stock - $0.001 par value; 26,666,667 shares authorized; 2,068,080 issued and 2,068,079 outstanding as of June 30, 2022, respectively.     2       -     (f)     2  
Additional paid-in capital     334,589       -           334,589  
Treasury stock, at cost, 1 share     (695 )     -           (695 )
Accumulated other comprehensive income     598       -           598  
Accumulated deficit     (281,463 )     (26,553 )   (c), (d), (e)     (308,016 )
                             
Stockholders’ Equity Attributable to Inpixon     53,031       (26,553 )         26,478  
                             
Non-controlling Interest     956       -           956  
                             
Total Stockholders’ Equity     53,987       (26,553 )         27,434  
                             
Total Liabilities, Mezzanine Equity and Stockholders’ Equity   $ 117,846     $ (32,317 )       $ 85,529  

 

The accompanying notes are an integral part of these unaudited pro forma condensed consolidated financial statements.

 

2

 

 

INPIXON AND SUBSIDIARIES

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the six months ended June 30, 2022

(In thousands, except number of shares and par value data)

 

    Inpixion and
Subsidiaries
Historical
(a)
    Pro Forma
Adjustments
    Note   Inpixion and
Subsidiaries Pro
Forma
 
Revenues   $ 9,956     $ (4,731 )   (g)   $ 5,225  
                             
Cost of Revenues     2,782       (1,129 )   (g)     1,653  
                             
Gross Profit     7,174       (3,602 )         3,572  
                             
Operating Expenses                            
Research and development     8,997       (4,421 )   (g)     4,576  
Sales and marketing     4,600       (2,676 )   (g), (h)     1,924  
General and administrative     13,002       (853 )   (g), (h)     12,149  
Acquisition-related costs     268       (16 )   (g)     252  
Impairment of goodwill     7,570       (5,540 )   (g)     2,030  
Amortization of intangibles     2,691       (1,948 )   (g)     743  
                             
Total Operating Expenses     37,128       (15,454 )         21,674  
                             
Loss from Operations     (29,954 )     11,852           (18,102 )
                             
Other Income (Expense)                            
Interest income (expense), net     178       (9 )   (g)     169  
Other expense, net     (771 )     234     (g)     (537 )
Unrealized loss on equity securities     (1,256 )     -           (1,256 )
Total Other Expense     (1,849 )     225           (1,624 )
                             
Net Loss, before tax     (31,803 )     12,077           (19,726 )
Income tax provision     (84 )     62     (g)     (22 )
Net Loss     (31,887 )     12,139           (19,748 )
                             
Net Loss Attributable to Non-controlling Interest     (804 )     -           (804 )
                             
Net Loss Attributable to Stockholders of Inpixon     (31,083 )     12,139           (18,944 )
Accretion of Series 7 preferred stock     (4,555 )     -           (4,555 )
Accretion of Series 8 Preferred Stock     (6,785 )     -           (6,785 )
Deemed dividend for the modification related to Series 8 Preferred Stock     (2,627 )     -           (2,627 )
Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock     1,469       -           1,469  
Amortization premium- modification related to Series 8 Preferred Stock     1,362       -           1,362  
Net Loss Attributable to Common Stockholders   $ (42,219 )   $ 12,139         $ (30,080 )
Basic and diluted loss per share   $ (21.68 )           (f)   $ (15.45 )
Weighted Average Shares Outstanding, basic and diluted     1,947,365             (f)     1,947,365  

 

The accompanying notes are an integral part of these unaudited pro forma condensed consolidated financial statements.

 

3

 

 

INPIXON AND SUBSIDIARIES

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the year ended December 31, 2021

(In thousands, except number of shares and par value data)

 

    Inpixion and
Subsidiaries
Historical
(b)
    Pro Forma
Adjustments
    Note   Inpixion and
Subsidiaries Pro
Forma
 
Revenues   $ 15,995     $ (6,368 )   (g)   $ 9,627  
                             
Cost of Revenues     4,374       (1,646 )   (g)     2,728  
                             
Gross Profit     11,621       (4,722 )         6,899  
                             
Operating Expenses                            
Research and development     14,121       (6,704 )   (g)     7,417  
Sales and marketing     8,261       (4,763 )   (g), (h)     3,498  
General and administrative     41,352       (21,137 )   (g), (h)     20,215  
Acquisition-related costs     1,248       (628 )   (g)     620  
Impairment of goodwill     14,789       (11,896 )   (g)     2,893  
Amortization of intangibles     4,467       (3,047 )   (g)     1,420  
                             
Total Operating Expenses     84,238       (48,175 )         36,063  
                             
Loss from Operations     (72,617 )     43,453           (29,164 )
                             
Other Income (Expense)                            
Interest income, net     1,183       (1 )   (g)     1,182  
Loss on exchange of debt for equity     (30 )     -           (30 )
Benefit for valuation allowance on related party loan - held for sale     7,345       -           7,345  
Other expense, net     (173 )     (81 )   (g)     (254 )
Gain on related party loan - held for sale     49,817       -           49,817  
Unrealized loss on equity securities     (57,067 )     -           (57,067 )
Total Other Income     1,075       (82 )         993  
                             
Net Loss, before tax     (71,542 )     43,371           (28,171 )
Income tax benefit (provision)     1,412       (2,527 )   (g)     (1,115 )
Net Loss     (70,130 )     40,844           (29,286 )
                             
Net Loss Attributable to Non-controlling Interest     (975 )     -           (975 )
                             
Net Loss Attributable to Stockholders of Inpixon     (69,155 )     40,844           (28,311 )
Accretion of Series 7 preferred stock     (8,161 )     -           (8,161 )
Net Loss Attributable to Common Stockholders   $ (77,316 )   $ 40,844         $ (36,472 )
Basic and diluted loss per share   $ (53.70 )           (f)   $ (25.33 )
Weighted Average Shares Outstanding, basic and diluted     1,439,753             (f)     1,439,753  

 

The accompanying notes are an integral part of these unaudited pro forma condensed consolidated financial statements.

 

4

 

 

INPIXON AND SUBSIDIARIES

NOTES TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION

 

(1) Basis of presentation

 

The unaudited pro forma condensed financial statements are based on the historical consolidated financial statements of the seller as adjusted to give effect to the Separation. The unaudited pro forma condensed consolidated statements of operations for the six months ended June 30, 2022, and the year ended December 31, 2021, give effect to the Separation as if it were completed on January 1, 2021. The unaudited pro forma condensed consolidated balance sheet as of June 30, 2022, gives effect to the Separation as if it were completed on June 30, 2022. The transaction accounting adjustments for the Separation consist of those necessary to account for the Separation.

 

(2) Unaudited Pro Forma Adjustments

 

The following is a summary of the unaudited pro forma adjustments reflected in the unaudited pro forma condensed consolidated financial statements based on preliminary estimates, which may change as additional information is obtained.

 

a. Reflects amounts as originally reported by the Company in its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022.

 

b. Reflects amounts as originally reported by the Company in its Annual Report on Form 10-K for the year ended December 31, 2021.

 

c. Reflects the elimination of the Enterprise Apps Business assets, liability and historical equity balances including within the Company’s consolidated financial statements. The amount of the actual gain will be calculated based on the net book value of the sold business as of the closing of the Business Combination and therefore could differ from the current estimate.

 

d. Reflects adjustment for remaining cash contribution of $3.8 million agreed upon within the Separation agreement.

 

e. Reflects adjustment for the stepped-up value of Inpixon’s investment in Class A and Class B Units of Cardinal Ventures Holdings LLC, which has certain interests in the sponsor of KINS. As such, Inpixon is entitled to an allocation of financial instruments distributed; assuming all public shareholders redeem as a result of the business combination Inpixon expects to receive 600,000 Class A shares of KINS and 2,500,000 private warrants. This results in an investment in equity securities of approximately $6.1 million assuming a $10.00 per share prices and an estimated value of the private warrants being determined based on a trading price of $0.036 per share as of October 14, 2022.

 

f. Reflects adjustment for reverse stock split of the Company’s authorized and issued and outstanding shares of common stock at a ratio of one (1) share of common stock for every seventy five (75) shares of common stock. The Company executed the reverse stock split on October 7, 2022.

 

g. Reflects the elimination of the historical revenues and expenses directly to related to the Enterprise Apps Business that will not recur in the Company’s consolidated statement of operations beyond a year from the date of the Business Combination.

 

h. Reflects management’s estimate of approximately $1.1 million and $.6 million of historical costs mainly executive salaries and benefits in general and administrative and sales and marketing expenses to replace shared personnel that were allocated to the Enterprise Apps Business that are needed to run the Company on a stand-alone basis added back to the statement of operations for the year ended December 31, 2021 and for the six months ended June 30, 2022, respectively.

 

 

5